These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1507 related items for PubMed ID: 6298039

  • 1. Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type I diabetes. Evidence for an effect mediated by beta-adrenoreceptors.
    Bolli G, de Feo P, Compagnucci P, Cartechini MG, Angeletti G, Santeusanio F, Brunetti P.
    Diabetes; 1982 Jul; 31(7):641-7. PubMed ID: 6298039
    [Abstract] [Full Text] [Related]

  • 2. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
    Rizza RA, Cryer PE, Gerich JE.
    J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
    [Abstract] [Full Text] [Related]

  • 3. Role of epinephrine-mediated beta-adrenergic mechanisms in hypoglycemic glucose counterregulation and posthypoglycemic hyperglycemia in insulin-dependent diabetes mellitus.
    Popp DA, Shah SD, Cryer PE.
    J Clin Invest; 1982 Feb; 69(2):315-26. PubMed ID: 6120181
    [Abstract] [Full Text] [Related]

  • 4. Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion.
    Bolli G, de Feo P, Compagnucci P, Cartechini MG, Angeletti G, Santeusanio F, Brunetti P, Gerich JE.
    Diabetes; 1983 Feb; 32(2):134-41. PubMed ID: 6337896
    [Abstract] [Full Text] [Related]

  • 5. Effect of propranolol on delayed glucose recovery after insulin-induced hypoglycemia in normal and diabetic subjects.
    Kleinbaum J, Shamoon H.
    Diabetes Care; 1984 Feb; 7(2):155-62. PubMed ID: 6376011
    [Abstract] [Full Text] [Related]

  • 6. Glucoregulation during exercise: hypoglycemia is prevented by redundant glucoregulatory systems, sympathochromaffin activation, and changes in islet hormone secretion.
    Hoelzer DR, Dalsky GP, Clutter WE, Shah SD, Holloszy JO, Cryer PE.
    J Clin Invest; 1986 Jan; 77(1):212-21. PubMed ID: 3511090
    [Abstract] [Full Text] [Related]

  • 7. Catecholamines in prevention of hypoglycemia during exercise in humans.
    Marker JC, Hirsch IB, Smith LJ, Parvin CA, Holloszy JO, Cryer PE.
    Am J Physiol; 1991 May; 260(5 Pt 1):E705-12. PubMed ID: 1674642
    [Abstract] [Full Text] [Related]

  • 8. Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin, and blood free fatty acid levels in man.
    Imura H, Kato Y, Ikeda M, Morimoto M, Yawata M.
    J Clin Invest; 1971 May; 50(5):1069-79. PubMed ID: 4928263
    [Abstract] [Full Text] [Related]

  • 9. The adrenergic contribution to glucose counterregulation in type I diabetes mellitus. Dependency on A-cell function and mediation through beta 2-adrenergic receptors.
    De Feo P, Bolli G, Perriello G, De Cosmo S, Compagnucci P, Angeletti G, Santeusanio F, Gerich JE, Motolese M, Brunetti P.
    Diabetes; 1983 Oct; 32(10):887-93. PubMed ID: 6311652
    [Abstract] [Full Text] [Related]

  • 10. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
    Saccà L, Sherwin R, Hendler R, Felig P.
    J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
    [Abstract] [Full Text] [Related]

  • 11. Glucoregulation during and after intense exercise: effects of beta-adrenergic blockade in subjects with type 1 diabetes mellitus.
    Sigal RJ, Fisher SJ, Halter JB, Vranic M, Marliss EB.
    J Clin Endocrinol Metab; 1999 Nov; 84(11):3961-71. PubMed ID: 10566635
    [Abstract] [Full Text] [Related]

  • 12. Higher glycemic thresholds for symptoms during beta-adrenergic blockade in IDDM.
    Hirsch IB, Boyle PJ, Craft S, Cryer PE.
    Diabetes; 1991 Sep; 40(9):1177-86. PubMed ID: 1657673
    [Abstract] [Full Text] [Related]

  • 13. Insulin, glucagon, and catecholamines in prevention of hypoglycemia during fasting.
    Boyle PJ, Shah SD, Cryer PE.
    Am J Physiol; 1989 May; 256(5 Pt 1):E651-61. PubMed ID: 2655471
    [Abstract] [Full Text] [Related]

  • 14. Adrenergic influence on glucocounterregulation in man.
    Lilavivat U, Brodows RG, Campbell RG.
    Diabetologia; 1981 Apr; 20(4):482-8. PubMed ID: 7016643
    [Abstract] [Full Text] [Related]

  • 15. No effect of beta-adrenergic blockade on hypoglycaemic effect of glucagon-like peptide-1 (GLP-1) in normal subjects.
    Toft-Nielsen M, Hvidberg A, Hilsted J, Dige-Petersen H, Holst JJ.
    Diabet Med; 1996 Jun; 13(6):544-8. PubMed ID: 8799658
    [Abstract] [Full Text] [Related]

  • 16. Impaired glucose disposal following mild hypoglycemia in nondiabetic and type I diabetic humans.
    Davis MR, Shamoon H.
    Metabolism; 1992 Feb; 41(2):216-23. PubMed ID: 1736045
    [Abstract] [Full Text] [Related]

  • 17. Lack of beta-adrenergic role for catecholamines in the development of hyperglycemia and ketonaemia following acute insulin withdrawal in type I diabetic patients.
    Beylot M, Sautot G, Dechaud H, Cohen R, Riou JP, Serusclat P, Mornex R.
    Diabete Metab; 1985 Apr; 11(2):111-7. PubMed ID: 2989015
    [Abstract] [Full Text] [Related]

  • 18. Attenuated glucose recovery from hypoglycemia in the elderly.
    Marker JC, Cryer PE, Clutter WE.
    Diabetes; 1992 Jun; 41(6):671-8. PubMed ID: 1587394
    [Abstract] [Full Text] [Related]

  • 19. α- or β-Adrenergic blockade does not affect transplanted islet cell responses to hypoglycemia in type 1 diabetes.
    Rickels MR, Bellin MD, Stefanovski D, Peleckis AJ, Dalton-Bakes C, Markmann E, Nguyen HL, Townsend RR, Hering BJ, Naji A.
    Am J Physiol Endocrinol Metab; 2024 Sep 01; 327(3):E290-E301. PubMed ID: 38984949
    [Abstract] [Full Text] [Related]

  • 20. Adrenergic blockade alters glucose kinetics during exercise in insulin-dependent diabetics.
    Simonson DC, Koivisto V, Sherwin RS, Ferrannini E, Hendler R, Juhlin-Dannfelt A, DeFronzo RA.
    J Clin Invest; 1984 Jun 01; 73(6):1648-58. PubMed ID: 6327767
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 76.